prof. dr. Wout Feitz
About Wout Feitz
Prof. dr. W.F.J. Feitz (Lichtenvoorde, 1957) studied Medicine in Nijmegen. He specialized in Urology (Fellow of the European Board of Urology) and specialized further in the field of Pediatric Urology (Fellow of the European Academy of Paediatric Urology). In 1993, he was appointed as Pediatric Urologist at the Department of Urology of the Radboud University Nijmegen Medical Centre. In 2001 he became associate professor and on 1 November 2006 full professor in Pediatric Urology at the Radboud University Nijmegen. The Pediatric Urology research program concerns congenital anomalies of the Urinary Tract and involves multidisciplinary collaborations within the research programs of the RUNMC and NCMLS and national and international collaborations. It involves the epidemiological and genetic aspects of congenital Urinary Tract Anomalies and Regenerative Urology and Tissue Engineering. He is currently the coördinator of the EU program EuroSTEC Soft tissue engineering for congenital birth defects (www.EuroSTEC.eu), advisor for the EU MultiTERM program (www.multitermproject.eu) and Program director of the training program for Pediatric Urology for the European Paediatric Urology Fellowship Program of The Joint Committee of Paediatric Urology (JCPU) of the EUMS, RUNMC (www.espu.org). He is the mentor of different student programs and an EUSP program for Pediatric Urology research in the field of tissue engineering.
Regenerative Medicine and pediatric urology. The research program of paediatric urology is focussed on congenital anomalies of the urogenital tract. It is incorporated within the RUNMC research programs of the Nijmegen Center of Molecular Life Sciences (NCMLS), Genetic and Metabolic Disorders and Prevention and Evaluation Research. The laboratory is located at the Experimental Urology Laboratory in the NCMLS Tower. The program currently involves urogenital tissue engineering and regenerative medicine (TERM), genetic and environmental factors in the etiology of urological defects in children (AGORA) and pediatric urology outcome research.